Page results
-
UCLH has teamed up with Air Ambulance Kent Surrey Sussex (KSS) to create an additional module to its Airway Matters, Massive Open Online Course (MOOC).
-
The latest copy of our magazine, Charity Matters is out now, available to read online or in hard copy in and around sites at UCLH hospitals.
-
There are just a few days left to share your views as part of a public consultation on proposed changes to how and where maternity, neonatal, and children’s surgical services could be provided in North Central London. The consultation closes on Sunday, 17 March 2024.
-
A directory of UK organisations which provide specialist support to anyone affected by cancer or a blood condition
-
Health and wellbeing information for people affected by cancer.
-
Health and wellbeing information for people affected by cancer.
-
This page has been written to tell you more about an outpatient hysteroscopy, why it is being done and what it involves.
-
A guide created by The Red Cell Network with expert patient insight from Elaine Tappin, Miriam Santos Freire and Nneka Smith.
-
A number of tests are carried out by the routine haemostasis/haematology laboratories. These include full blood count, ESR, sickle cell and glandular fever screening, malaria antigen testing, blood films and acanthocytes, coagulation screens (INR/heparin monitoring), fibrinogen and D-dimers (DIC screening).
-
Information on safer eating during treatment, for patients with blood cancer.
File results
-
FOI/2023/0815 - Birth data; live births/ stillbirths/ neonatal deaths
-
FOI/2023/0817 - Bed sores, pressure sores and pressure ulcers statistics
-
FOI/2023/0822 - Bank staff pay rates
-
FOI/2023/0827 - Consultation on future of EDS services
-
FOI/2023/0829 - Immunoglobulin treatments
-
FOI/2023/0831 - Treatments for acute myeloid leukaemia/ chronic lymphocytic leukaemia
-
FOI/2023/0832 - Hospital admissions for vaping related disorders
-
FOI/2023/0833 - Evaluation of outpatient referrals to neurosurgical department
-
FOI/2023/0836 - Translation services and technologies
-
FOI/2023/0837 - Treatment for Myelofibrosis